Meningococcal Disease in the Middle East and North Africa: An Important Public Health Consideration That Requires Further Attention
This paper, published in International Journal of Infectious Diseases, reviews the epidemiological data describing meningococcal disease in the Middle East and North Africa (MENA). The authors found that, while meningococcal disease remains an important cause of endemic and epidemic disease in many MENA countries, existing published epidemiological data appear limited, fragmented, and collected via disparate methodologies. They assert that strengthening regional surveillance systems and regularly publishing reports with reliable estimates may facilitate the development of appropriate interventions and public health strategies regarding meningococcal disease within the region. Further, wider use of available polyvalent meningococcal conjugate vaccines may provide broader protection against the range of serogroups causing disease or posing a threat in the region. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author(s): Ceyhan M, Anis S, Htun-Myint L, Pawinski R, Soriano-Gabarró M, Vyse A
Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Ceyhan M, Anis S, Htun-Myint L, Pawinski R, Soriano-Gabarró M, Vyse A. Meningococcal Disease in the Middle East and North Africa: an Important Public Health Consideration That Requires Further Attention. International Journal of Infectious Diseases. 2012;16(8):e574–e582.